Magnesium orotate

Magnesium orotate
Clinical data
AHFS/Drugs.comConsumer Drug Information
ATC code
Identifiers
IUPAC name
  • magnesium 2,6-dioxo-3H-pyrimidine-4-carboxylate
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.047.410
Edit this at Wikidata
Chemical and physical data
FormulaC10H6MgN4O8
Molar mass334.483 g·mol−1
3D model (JSmol)
SMILES
  • [Mg+2].O=C([O-])\C1=C\C(=O)NC(=O)N1.[O-]C(=O)\C1=C\C(=O)NC(=O)N1
InChI
  • InChI=1S/2C5H4N2O4.Mg/c2*8-3-1-2(4(9)10)6-5(11)7-3;/h2*1H,(H,9,10)(H2,6,7,8,11);/q;;+2/p-2
  • Key:QWLHYYKDLOVBNV-UHFFFAOYSA-L
  (verify)

Magnesium orotate, the magnesium salt of orotic acid, is a mineral supplement. It can be used in treating extracellular magnesium deficiency, as well as in mitigating magnesium depletion that inhibits the binding of adenosine triphosphate via orotic acid, which provides binding sites.[1]

References

  1. Classen HG (2004). "Magnesium orotate--experimental and clinical evidence". Romanian Journal of Internal Medicine = Revue Roumaine de Médecine Interne. 42 (3): 491–501. PMID 16366126.


This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.